Marina Planas: MRD and Molecular Monitoring Take Center Stage at EHA 2026
Marina Planas, CEO and Co-Founder, Chief Strategy Officer (CSO) and Board Member at Altum Sequencing, shared a post on LinkedIn:
“European Hematology Association (EHA) 2026 confirmed something we strongly believe at Altum Sequencing:
The future of hematology will be increasingly shaped by MRD and molecular monitoring.
Over the past few days in Stockholm, one theme appeared repeatedly across scientific sessions and industry discussions: the need to detect response, resistance and relapse earlier, with greater precision and actionable insights.
This year’s congress was also a special milestone for Altum Sequencing.
For the first time, we exhibited with our own stand at the European Hematology Association (EHA).
Over four intense days, we strengthened relationships with existing customers, initiated discussions with prospective customers, and met with pharmaceutical companies, clinicians, principal investigators, industry partners and technology leaders shaping the future of precision medicine.
Seeing Joaquin Martinez and Rosa Ayala at our stand, together with an exceptional Altum Sequencing team, was a powerful reminder that transformative companies are built when scientific excellence meets execution.
We return from Stockholm with new opportunities, stronger partnerships and even greater ambition.
We believe MRD and molecular monitoring will become a standard component of cancer care.
And Altum Sequencing intends to help make that future a reality.”
Stay updated with Hemostasis Today.
-
Nov 13, 2026, 03:21Abdul Muqtadir Abbasi: Iron Deficiency Beyond Anemia and the Importance of Finding the Cause
-
Nov 13, 2026, 03:05Marc Carrier: Aspirin vs Anticoagulants for VTE Prevention After Joint Replacement
-
Nov 13, 2026, 02:28Julia Sjöberg: ROCK1 Inhibition and Red Blood Cell Recovery After Chemotherapy
-
Nov 13, 2026, 02:07Tonie Reincke: Understanding Deep Vein Thrombosis and Vascular Health
-
Nov 13, 2026, 01:52Akshita Singh: The Remarkable Process of Blood Clotting
-
Nov 12, 2026, 22:52Milka Koupenova: The Role of Platelet RIG-I in Regulating Thrombotic Responses
-
Nov 12, 2026, 22:50Arun V J: Why Has India Still Not Achieved 100% Voluntary Blood Donation?
-
Nov 12, 2026, 22:49Sickle Cell Disease Deserves to Be Prioritised in Ghana – ISCC
-
Nov 12, 2026, 22:47Samir Kumar Beura: Delighted to Serve as a Topic Editor for a Research Topic in Frontiers in Neuroscience